How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?

ABSTRACT:

Background

A national serosurvey of U.S. blood donors conducted in partnership with the Centers for Disease Control and Prevention (CDC) was initiated to estimate the prevalence of SARS-CoV-2 infections and vaccinations.

Methods

Beginning in July 2020, the Nationwide Blood Donor Seroprevalence Study collaborated with multiple blood collection organizations, testing labs, and leadership from government partners to capture, test, and analyze approximately 150,000 blood donation specimens per month in a repeated, cross-sectional seroprevalence survey.

Results

A CDC website (https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence) provided stratified, population-level results to public health professionals and the general public.

Discussion

SUBMITTER: Fink RV 

PROVIDER: S-EPMC9348230 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature